MDMA or related drug-induced psychotic disorder, including MDA (Q40433): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Transtorno psicótico induzido por MDMA ou drogas relacionadas, incluindo MDA, é caracterizado por sintomas psicóticos (p. ex., delírios, alucinações, pensamento desorganizado, comportamento grosseiramente desorganizado), que se desenvolvem durante ou logo após intoxicação por MDMA ou drogas relacionadas. A intensidade ou duração dos sintomas é consideravelmente maior do que alterações de percepção, cognição ou comportamento do tipo psicótico que são características de intoxicação por MDMA ou drogas relacionadas. A quantidade e duração do uso de MDMA ou drogas relacionadas devem ser capazes de produzir sintomas psicóticos. Os sintomas não são mais bem explicados por um transtorno mental primário (p. ex., esquizofrenia, transtorno do humor com sintomas psicóticos), como pode ser o caso se os sintomas psicóticos precederam o início do uso de MDMA ou drogas relacionadas, se os sintomas persistem por um período de tempo considerável após a cessação do uso de MDMA ou drogas relacionadas, ou se há outra evidência de um transtorno mental primário com sintomas psicóticos preexistente (p. ex., história de episódios anteriores não associados ao uso de MDMA ou drogas relacionadas, incluindo MDA). | |||||||||||||||
| description / en | description / en | ||||||||||||||
MDMA or related drug-induced psychotic disorder, including MDA is characterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised thinking, grossly disorganised behaviour) that develop during or soon after intoxication with MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of psychotic-like disturbances of perception, cognition, or behaviour that are characteristic of MDMA or related drug intoxication. The amount and duration of MDMA or related drug use must be capable of producing psychotic symptoms. The symptoms are not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the case if the psychotic symptoms preceded the onset of the MDMA or related drug use, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug use, or if there is other evidence of a pre-existing primary mental disorder with psychotic symptoms (e.g., a history of prior episodes not associated with MDMA or related drug use, including MDA). | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1589999330 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:6C4C.6 | |||||||||||||||
| Property / CURIE: CID11:6C4C.6 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-6C4C.6 | |||||||||||||||
| Property / Canary Token: dki-india-6C4C.6 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: F15.5 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 06:14, 13 August 2026
MDMA or related drug-induced psychotic disorder, including MDA is characterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised thinking, grossly disorganised behaviour) that develop during or soon after intoxication with MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of psychotic-like disturbances of perception, cognition, or behaviour that are characteristic of MDMA or related drug intoxication. The amount and duration of MDMA or related drug use must be capable of producing psychotic symptoms. The symptoms are not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the case if the psychotic symptoms preceded the onset of the MDMA or related drug use, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug use, or if there is other evidence of a pre-existing primary mental disorder with psychotic symptoms (e.g., a history of prior episodes not associated with MDMA or related drug use, including MDA).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 6C4C.6 |
||
| English | MDMA or related drug-induced psychotic disorder, including MDA |
MDMA or related drug-induced psychotic disorder, including MDA is characterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised thinking, grossly disorganised behaviour) that develop during or soon after intoxication with MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of psychotic-like disturbances of perception, cognition, or behaviour that are characteristic of MDMA or related drug intoxication. The amount and duration of MDMA or related drug use must be capable of producing psychotic symptoms. The symptoms are not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the case if the psychotic symptoms preceded the onset of the MDMA or related drug use, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug use, or if there is other evidence of a pre-existing primary mental disorder with psychotic symptoms (e.g., a history of prior episodes not associated with MDMA or related drug use, including MDA). |
Statements
CID11:6C4C.6
0 references
dki-india-6C4C.6
0 references
Concluído
0 references
13 August 2026
0 references
